No Data
Asia Pacific Pharmaceuticals: 2024 Annual Report Summary
Asia Pacific Pharmaceuticals: Annual Report 2024
Zhejiang Yatai Pharmaceutical (002370.SZ): received a government subsidy of 3 million yuan.
Gelonghui April 18丨Zhejiang Yatai Pharmaceutical (002370.SZ) announced that the company recently received a government subsidy of 3 million yuan, accounting for 25.26% of the absolute value of the Net income attributable to the listed company's Shareholders in the most recent audited period.
Shareholders in Zhejiang Yatai Pharmaceutical (SZSE:002370) Have Lost 53%, as Stock Drops 16% This Past Week
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.
Zhejiang Yatai Pharmaceutical (002370.SZ): intends to transfer 100% equity of Xingya Pharmaceutical to Zhejiang Zhongqingda.
On March 31, Gelonghui reported that Zhejiang Yatai Pharmaceutical (002370.SZ) announced that on March 31, 2025, the company signed the "Equity Transfer Agreement regarding Shaoxing Xingya Pharmaceutical Co., Ltd." with Zhejiang Zhongqingda Construction Industry Co., Ltd. (hereinafter referred to as "Zhejiang Zhongqingda" or "the transferee"), transferring 100% of the shares of Shaoxing Xingya Pharmaceutical Co., Ltd. (hereinafter referred to as "Xingya Pharmaceutical" or "the symbol company") held by the company to Zhejiang Zhongqingda. As of the date of signing the Equity Transfer Agreement, Xingya Pharmaceutical owes the company a loan of RMB 48.7289 million. Through mutual agreement, this Trade adopts a debt assumption.
Some Zhejiang Yatai Pharmaceutical Co., Ltd. (SZSE:002370) Shareholders Look For Exit As Shares Take 26% Pounding
